Pulmonary paracoccidioidomycosis associated with the use of natalizumab in multiple sclerosis-Reference-Cited by-同舟云学术

Pulmonary paracoccidioidomycosis associated with the use of natalizumab in multiple sclerosis

Published:2018-04-13 Issue:7 Volume:24 Page:1002-1004
ISSN:1352-4585
Container-title:Multiple Sclerosis Journal
language:en
Short-container-title:Mult Scler

Author:

Almeida Kelson James¹^ORCID,Barreto-Soares Raissa Viera²,Campos-Sousa Raimundo Nonato³,Campos-Sousa Maria Graças³,Bor-Seng-Shu Edson⁴

Affiliation:

1. Department of Neurology, Central Institute, Clínicas Hospital, University of São Paulo, São Paulo, Brazil

2. Facid Devry Faculty of Medicine, Teresina, Brazil

3. Department of Neurology, Federal University of Piauí, Teresina, Brazil

4. Division of Neurosurgery, Department of Neurology, University of São Paulo, São Paulo, Brazil

Abstract

Background: Natalizumab (NTZ) is a monoclonal antibody with an immunosuppressive effect that reduces the inflammation of the central nervous system, and it has been used for the treatment of relapsing-remitting multiple sclerosis (RRMS). In patients with low cellular immune response, systemic mycosis arising from endemic areas may occur. Results and Conclusion: In this article, we will describe a case of paracoccidioidomycosis as a complication to treatment with NTZ in an RRMS patient.

Publisher

SAGE Publications

Subject

Clinical Neurology,Neurology

Link

http://journals.sagepub.com/doi/pdf/10.1177/1352458518763091

Reference5 articles.

1. Natalizumab: α4-integrin antagonist selective adhesion molecule inhibitors for MS

2. Natalizumab treatment for multiple sclerosis: updates and considerations for safer treatment in JCV positive patients

3. Consenso em paracoccidioidomicose

4. Basic and escalating immunomodulatory treatments in multiple sclerosis: Current therapeutic recommendations

5. Blocking adhesion molecules as therapy for multiple sclerosis: natalizumab

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Infections in the era of immunobiologicals;Anais Brasileiros de Dermatologia;2024-03

2. The risk of infections for multiple sclerosis and neuromyelitis optica spectrum disorder disease-modifying treatments: Eighth European Committee for Treatment and Research in Multiple Sclerosis Focused Workshop Review. April 2021;Multiple Sclerosis Journal;2022-02-23

3. Guías de práctica para indicación y contraindicaciones de vacunación de pacientes con esclerosis múltiple;Neurología Argentina;2021-01

4. New Insights on Pulmonary Paracoccidioidomycosis;Seminars in Respiratory and Critical Care Medicine;2020-01-30

5. Invasive fungal diseases in patients with rheumatic diseases;Handbook of Systemic Autoimmune Diseases;2020